Want to join the conversation?
$HPE's revenue was down slightly on an operational basis in 3Q16, but the company saw many areas of growth in key parts of its portfolio, including networking, all flash storage, high performance compute and technology services. Free cash flow improved to $1 Bil and $HPE returned $1.5 Bil to shareholders mainly through share repurchases.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.